GovChime
Notice ID: e2a7a0592bfc4d43a0ab18d0c39147d3Solicitation

BROAD AGENCY ANNOUNCEMENT - BIOMEDICAL RESEARCH AND DIVING EQUIPMENT DEVELOPMENT

Active, responses due . Full description on SAM.gov.

Overview

Response deadline
3:00 PM EST
Posted
September 23, 2026
Notice type
Solicitation
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)
Agency
Department of WarDepartment of the Navy

Notice details

Office
NAVSEA.NAVSEA HQ.NAVSEA HQ
Place of performance
Washington Navy Yard, District of Columbia
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
N0002427S0001
Notice ID
e2a7a0592bfc4d43a0ab18d0c39147d3

Description

Broad Agency Announcement (BAA) for BAA N00024-27-S-0001 BIOMEDICAL RESEARCH AND DIVING EQUIPMENT DEVELOPMENT IN THE AREAS OF DIVER HEALTH, SAFETY, AND EFFECTIVENESS, AS WELL AS SUBMARINER SURVIVABILITY IN A DISABLED SUBMARINE

Naval Sea Systems Command (NAVSEA) is soliciting pre-proposals and full proposals for applied Biomedical Research and Diving Equipment Development with a focus on Diver Health, Safety, and Performance, Deep Diving Advancements, and Submarine Escape and Rescue.  The program’s goals are presented in detail below. It is the intent that this Broad Agency Announcement (BAA) be open for a two-year period from the date of publication.  Specified dates are given in paragraph 2.a. below for submission of pre-proposals and full proposals to be awarded within Fiscal Year (FY) 2028 and 2029.

1.  Primary Areas of Interests

Program objectives are to focus research on improving or developing diving equipment for rapid transition to fleet capabilities, and biomedical aspects of Diver Health, Safety, and Performance, Deep Diving, and Submarine Escape and Rescue to develop and/or improve procedures that increase Navy personnel safety and effectiveness.  The typical project will be two years or less, although three-year projects will be considered. Contracts awarded as a result of these BAAs historically average around $300K or less in annual cost. This information is provided for informational purposes only to provide a sense of scope desired by NAVSEA. This is not an obligatory value and pre-proposals/proposals valued above or below will be considered. However, budgetary constraints are a deciding factor in the selection for award.

      a. Diving:  This interest area is comprised of five task areas focused on items that impose limitations on diver capabilities, specifically: breathing gas supply; human performance; protection from the undersea environment; decompression; and tools, transportation and training.  Focus areas for each task are:

  1. Breathing Gas Supply (product goal should meet both US Navy General Specification for Diving and Manned Hyperbaric Systems and US Navy Dive annual requirements):
    • Improve carbon dioxide (CO2) scrubbing materials or systems (i.e. canister systems), used for both free-swimming (i.e. underwater breathing apparatuses (UBAs)) and fixed systems (i.e. recompression chambers), that extend diving duration;
    • Develop portable, minimal power input, ambient oxygen (O2) concentrators capable of working in conjunction with existing diving air compressors;
    • Improve helium reclaim systems to support mixed gas and saturation diving systems and compact, portable mix-making system to reduce large gas storage logistical footprints;
    • Develop CO2 sensor and improve O2 sensors for measuring ppO2 in closed-circuit UBA;
    • Develop innovative diluent gas solutions that combine the advantages of nitrogen’s abundance and availability and helium’s non-narcotic properties;
    • Develop high-pressure air flasks, hoses and regulators, with high pressure defined for this purpose as greater than 5,000 pounds per square inch (psi), for surface-supplied diving (SSD) emergency gas supplies (EGS) and SCUBA/ closed and semi-closed UBAs. Current diver worn EGS is not sufficient to provide organic gas supply for recovery from deepest depths if primary gas source is lost.

  1. Human Performance:
    • Improve understanding of oxygen toxicity mechanisms and oxygen toxicity mitigation development;
    • Develop pharmacological or other novel mitigations to prevent or delay pulmonary and CNS oxygen toxicity;
    • Develop and/or refine underwater noise protection strategies, equipment, and diver underwater exposure limits;
      • Improve current comprehension of the environmental and physiological mechanisms via which sound is perceived via wetted auditory interface;
      • Develop permissible exposure limits (PEL) for typical broadband noise sources in the aquatic mission environment;
      • Develop compact, adaptive, wearable acoustic dosimetry technology for use in conjunction with PEL and to inform long-term auditory hazards associated with diving; 
      • Develop methods to assess and mitigate diver underwater sound/blast/implosion exposure.
    • Refine the understanding of hypercapnia and its effects on divers and mitigations thereof;
    • Improve understanding of gas (N2, O2, CO2) narcosis to include mitigations and predictions of equivalent narcotic depths;
    • Improve understanding of effects on the human body from immersion, exertion, breathing resistance, and temperature, or a combination thereof, in relation to working underwater;
    • Develop breathing standards for resting and working personnel in dry hyperbaric environments to 6 Atmospheres Absolute (ATA).

(3)  Protection from the Environment:   

  • Improve knowledge of submerged body heat loss/retention to inform development of future heating/cooling systems; Develop analytical tools for exposure planning for deep / long duration diving operations based off know levels of thermal protection and environmental factors (i.e. depth, temperature, etc.);
  • Improve heating/cooling methods/systems for submerged free-swimming divers; Examine novel mechanism for actively cooling a diver underwater. Specifically in helmeted or unhelmeted and tethered and untethered conditions. The system should be capable of functioning in a highly contaminated environment;
  • Improve physical protection for divers in contaminated water (i.e. full encapsulation) to include novel non-permeable membranes;
  • Improve equipment and procedures used to decontaminate divers and diving gear;
  • Improve equipment and/or procedures to detect and quantify biologic and/or chemical contamination on-site within 24 hours of diving;
  • Develop permissible exposure limits for common biological/chemical contaminants for risk mitigation planning.

(4)  Decompression:  

  • Develop/test decompression models valid across the full spectrum of U.S. Navy diving, including diving to depths beyond 300 fsw;
  • Develop pharmacological or other novel mitigations for preventing or treating decompression sickness;
  • Improve decompression sickness diagnosis through, but not limited to, the utilization of algorithms;
  • Improve decompression guidance using alternate gas mixtures.

(5)  Tools, Transportation and Training:

  • Improve diver communications, both wired and through-water;
  • Improve the ability to track diver location underwater from surface support craft;
  • Improve through-water data communication for divers (text, navigation, biometrics);
  • Improve diver propulsion devices to include diver worn and diver as passenger.

      b.   Submarine Escape and Rescue:  This interest area relates to optimizing submariner survival in a disabled submarine event.  Focus areas are:  

  • Development of rapid, accurate methods to assess a disabled submarine (DISSUB) atmosphere, with focus on Submarine Escape Action Limit (SEAL) gases, to internal pressures up to 6 ATA;
  • Develop novel means to mitigate oxygen toxicity (Pulmonary and CNS) aboard a pressurized disabled submarine;
  • Develop novel means to accelerate or eliminate saturation decompression of a pressurized disabled submarine (DISSUB) survivors, including but not limited to, greater oxygen use;  
  • Evaluation of the utility of non-hyperbaric interventions to prolong survival and accelerate decompression from a pressurized DISSUB;
  • Evaluation of the impact of starvation, dehydration, sleep deprivation, and/or gas narcosis at 2- 5 atmospheres absolute (ATA) on decision making in a pressurized DISSUB;
  • Improve understanding and guidance of thermal stress (with focus on hyperthermia) and associated fluid loss in a pressurized DISSUB and rescue vehicles to 5 ATA by:
    • Development and evaluation of physiological heat stress limits based on time and environmental conditions, and
    • Development and evaluation of heat mitigation measures (body cooling) under conditions of increased temperature, humidity, and elevated CO2 (2.5 - 3%);
  • Improve understanding and guidance for mitigation of surface interval decompression sickness (DCS) risk associated with rescue using either the Pressurized Rescue Module (PRM) or the Submarine Rescue Chamber (SRC) after saturation dropout or aborted decompression, including, but not limited to, mitigation with various periods of oxygen pre-breathing and/or other non-hyperbaric interventions e.g. pharmacological;
  • Develop procedures to fully decompress pressurized rescuees within the PRM if needed;
  • Improve guidance for hypothermia prevention in submarine escape scenarios using existing Submarine Escape and Surface Survival Personnel Equipment (SESSPE);
  • Improve Guard Book guidance, procedures, and related senior survivor decision tools, to include reducing the risk of pulmonary oxygen toxicity for rescuees;
  • Improve care of escape and rescue casualties within the U.S. Navy Submarine Rescue Diving and Recompression System (SRDRS), to include critical care and casualty assessment;
  • Improvement of current concepts of rescuee triage, holding, and movement, including assessment of the adequacy of established procedures and available equipment, for rescues involving the PRM and the SRC;
  • Improvement of current tracking of rescuee triage, holding, and movement.

      c.  Additional interest items include any equipment, procedure, or medical treatment protocol, not specifically listed above, that could be used to improve the safety or effectiveness of Navy divers or submarine rescue operations.

2.  Instructions for Preparation of Pre-proposal and Proposals

a. Proposals to this BAA are reviewed using a two-phase process.  To be considered for an award, respondents are first required to submit a pre-proposal. Multiple submissions are allowed and encouraged if a respondent wishes to be considered for award under more than one of the task areas identified above. Separate submissions are required for each area of interest.

(1)  For FY28, the pre-proposal submission deadline is no later than 3:00 PM EST, 30 November 2026.  If the pre-proposal submission is selected, the second phase will be a request for proposals.  The deadline for proposal submission is no later than 3:00 PM EST, 30 March 2027.  Proposals received after the due date will be considered only if funding remains available.  These dates are applicable to work beginning in the funding cycle starting 1 October 2027.

(2)  For FY29, the pre-proposal submission deadline is no later than 3:00 PM EST, 30 November 2027.  If the pre-proposal submission is selected, the second phase will be a request for full-proposals.  The deadline for proposal submission is no later than 3:00 PM EST, 30 March 2028.  Proposals received after the due date will be considered only if funding remains available.  These dates are applicable to work beginning in the funding cycle starting 1 October 2028.

b. The Phase One pre-proposal shall be three to five pages of text using the format provided with this BAA, and should include an estimate of overall costs (including indirect costs) for each year of the proposed effort.  Pre-proposals will be evaluated based on the criteria specified below using a scale of 1 (lowest) to 10 (highest).

c. The highest rated pre-proposal responses will be invited to submit a Phase Two full technical and cost proposal on all or part of their pre-proposal submission. The technical proposal will be submitted using the format provided with this BAA and not be more than 20 pages excluding curriculum vitae and supporting documentation that would be included in the Appendix. Any such invitation does not obligate the U.S. Government to make an award.  Offerors are also advised all awards are subject to the Defense Contract Audit Agency (DCAA) contract audit process.  Any proposal that involves animal research must comply with the following requirements before a contract can be awarded: 7 U.S.C. 2131-2159 and 9 CFR parts 1 thru 4, SECNAVINST 3900.38C, DoDINST 3216.01 and Defense Federal Acquisition Regulation Supplement (DFARS) 252.235-7002 Animal Welfare, as applicable.  Additionally, any proposal that involves human subject research must comply with the following requirements before a contract can be awarded:  32 CFR 219, DoDINST 3216.02, the SECNAVINST 3900.39 series, and all applicable sections of the 21 CFR as outlined in DFARS 252.235-7004 Protection of Human Subjects.  Each pre-proposal and full proposal must state that it is submitted in response to this BAA.  This BAA provides no funding for pre-proposal or subsequent proposal development purposes.  Proposals will be evaluated based on the criteria specified below.

3.  Criteria for Scoring and Ranking Pre-proposals and Proposals, their Relative Importance, and the Method of Evaluation.

a. Pre-proposal and full technical proposal submissions will be evaluated on:

      (1) the basis of innovation and scientific merit;

      (2) the relevance to diving and submarine escape and rescue;

      (3) the overall value to the U.S. Government and affordability of the proposal;

      (4) the likelihood of achieving success, based on the Offeror’s abilities, capabilities, strengths, and weaknesses, all of which impact the ability to achieve the proposal objectives;

(5) the potential benefits of any proposed data rights (if applicable);

(6) the ability of the offeror to efficiently manage their project, funds and timely completion of work products; and

(7) The overall impression of the project by the expert reviewer(s). 

These criteria are all of equal importance. Each of these criteria will be evaluated on a score of 1 (lowest) to 10 (highest) and the final score will be an average of the score for each criterion.

b. Selection of proposals for award will be based on the total evaluated score of the items above. The scoring is awarded as follows:  poor: 1-3, fair: 4-5, good: 6-8, excellent: 9-10.

Scores are assigned by individual reviewers and averaged by the program manager.  Final decisions for funding are based on the scores received and ties are broken by discussion and re-vote at the technical advisory board meeting.

c. This is to notify potential Offerors that each contract that may be placed under this announcement to an institution of higher education must include the following clause:

"As a condition for receipt of funds available to the Department of Defense (DoD) under this award, the recipient agrees that it is not an institution that has a policy of denying, and that it is not an institution that effectively prevents the Secretary of Defense from obtaining for military recruiting purposes:  (A) an entry to campuses or access to students on campuses; or (B) access to directory information pertaining to students.  If the recipient is determined, using procedures established by the Secretary of Defense to implement Section 558 of Public Law 103-337 (1994), to be such an institution during the period of performance of this agreement, and therefore to be in breach of this clause, the Government will cease all payments of DoD funds under this agreement and all other DoD grants and cooperative payments unilaterally for material failure to comply with the terms and conditions of award.  If your institution has been identified under the procedures established by the Secretary of Defense to implement Section 558, then: (1) no funds available to DoD may be provided to your institution through any contract, including any existing contract, (2) as a matter of policy, this restriction also applies to any cooperative agreement, and (3) your institution is not eligible to receive a contract or cooperative agreement in response to this solicitation."

d. This announcement constitutes a Broad Agency Announcement (BAA) as contemplated in FAR 6.102(d)(2)(i).  The Government reserves the right to select for award all, some, or none of the proposals received in response to this announcement.

4.  Pre-proposals and subsequent proposals shall be submitted to: Dr. David Southerland, david.g.southerland.civ@us.navy.mil; usn.washington.sea-00.mbx.sea-00c-dsbd@us.navy.mil

 and lisa.m.grayum.civ@us.navy.mil, Attn: BAA N00024-27-S-0001.  Offerors are to follow the sample format for submission of pre-proposals and proposals as found in enclosures (1) and (2) of this BAA. 

a. All pre-proposals and proposals will be acknowledged within 7 working days after the published due date.  If no acknowledgement is received after 7 working days it is the responsibility of the submitter to contact the Naval Sea Systems Command office at 202-781-3854 to verify that their submission has been received. Pre-proposals and proposals will not be returned after evaluation.  General and technical questions regarding this announcement should be sent to: usn.washington.sea-00.mbx.sea-00c-dsbd@us.navy.mil

b. The point of contact for information regarding contractual issues is Ms. Lisa Grayum, Contracting Officer, at email: lisa.m.grayum.civ@us.navy.mil and Ms. Ashala Bell, Contract Specialist, at email: ashala.d.bell.civ@us.navy.mil.  The following additional information is provided:

(1) Proposals may be submitted by any governmental agency, commercial firm, individual, non-profit, or institution of higher education.

(2) Offerors must be current in System for Award Management (SAM).

   

c.  Phase Two of the proposal selection process for non-government institutions (contractors) will consist of a request from the U.S. Government to the Offeror(s) for full technical and cost proposals to support the Navy in one or more of the primary areas of interest listed in paragraph 1 above.  An Offeror can be considered for contract award only upon preparation and submittal of a fully compliant Phase Two Proposal. In the event that a Phase Two technical and cost proposal is requested, the applicable Request for Proposal will contain the terms and conditions and clauses to be incorporated in the potential contract.

5. Any contract(s) awarded based on responses to this BAA are considered to be the result of full and open competition (see FAR 6.102(d)(2)(i)) and in full compliance with the provisions of Public Law (PL) 98-369, “The Competition in Contracting Act of 1984.”

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

Files (2)

  • BAA - DSBD and Diving Equipment Encl 2 - Proposal Format.docx

    63 KBAdded in Solicitation version 1Posted
    Download
  • BAA - DSBD and Diving Equipment Encl 1 - Pre-proposal Format.docx

    35 KBAdded in Solicitation version 1Posted
    Download

Lifecycle

  1. 1
    Version 1SolicitationCurrent

    BROAD AGENCY ANNOUNCEMENT - BIOMEDICAL RESEARCH AND DIVING EQUIPMENT DEVELOPMENT

    Notice e2a7a0592bfc4d43a0ab18d0c39147d3 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
We appreciate your interest in partnering with BARDA. The latest BARDA Broad Agency Announcement (BAA) is Amendment 7 posted on March 19, 2026. All contracting-related inquiries should be sent to BARDA-BAA@hhs.gov. The final proposal submission deadline is September 25, 2028, at 4:30 PM Eastern Time for open areas of interest.
80%
Solicitation09/25/2028
This BAA is intended to solicit extramural research and development ideas using the authority provided by United States Code, Title 10, Section 4001. This BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in Federal Acquisition Regulation 6.102(d) (2) and 35.016. In accordance with FAR 6.102, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funding through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA provides a general description of USSOCOM's research and development programs, including research areas of interest, evaluation and selection criteria, pre-proposal/pre-application and full proposal/application preparation instructions, and general administrative information. Submission of a pre-proposal is required. After review, if the USSOCOM is interested in receiving a full proposal, the Offeror will be invited to submit a full proposal or full application. Specific submission information and additional administrative requirements can be found in the document titled "General Submission Instructions" available in Grants.gov along with this BAA The BAA is continuously open for a 5-year period, from 01 August 2023 through 31 July 2028, at 11:59 p.m. Eastern Time. Submission of a pre-proposal is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Preproposals may be submitted at any time throughout the 5-year period. If the USSOCOM is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this BAA through 31 July 2028. The BAA with revised research areas of interests, and General Submission Instructions is available for download on Grants.gov. Search opportunity number HT9425-23-S-SOC1.
71%
Special Notice07/31/2028
This BAA is intended to solicit extramural research and development ideas using the authority provided by United States Code, Title 10, Section 4001. This BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in Federal Acquisition Regulation 6.102(d) (2) and 35.016. In accordance with FAR 6.102, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funding through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA provides a general description of USSOCOM's research and development programs, including research areas of interest, evaluation and selection criteria, pre-proposal/pre-application and full proposal/application preparation instructions, and general administrative information. Submission of a pre-proposal is required. After review, if the USSOCOM is interested in receiving a full proposal, the Offeror will be invited to submit a full proposal or full application. Specific submission information and additional administrative requirements can be found in the document titled "General Submission Instructions" available in Grants.gov along with this BAA The BAA is continuously open for a 5-year period, from 01 August 2023 through 31 July 2028, at 11:59 p.m. Eastern Time. Submission of a pre-proposal is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Preproposals may be submitted at any time throughout the 5-year period. If the USSOCOM is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this BAA through 31 July 2028. The BAA with revised research areas of interests, and General Submission Instructions will be available for download on Grants.gov upon revisions. Search opportunity number HT9425-23-S-SOC1.
71%
Special Notice07/31/2028
Broad Agency Announcement (BAA) for BAA-25-G-01 BIOMEDICAL RESEARCH AND DIVING EQUIPMENT DEVELOPMENT IN THE AREAS OF DIVER HEALTH, SAFETY, AND EFFECTIVENESS, AS WELL AS SUBMARINER SURVIVABILITY IN A DISABLED SUBMARINE Naval Sea Systems Command (NAVSEA) is soliciting pre-proposals and full proposals for applied Biomedical Research and Diving Equipment Development with a focus on Diver Health, Safety, and Performance, Deep Diving Advancements, and Submarine Escape and Rescue. The program’s goals are presented in detail below. It is the intent that this Broad Agency Announcement (BAA) be open for a two-year period from the date of publication. Specified dates are given in paragraph 2.a. below for submission of pre-proposals and full proposals to be awarded within Fiscal Year (FY) 2026 and 2027. 1. Primary Areas of Interests Program objectives are to focus research on improving or developing diving equipment for rapid transition to fleet capabilities, and biomedical aspects of Diver Health, Safety, and Performance, Deep Diving, and Submarine Escape and Rescue to develop and/or improve procedures that increase Navy personnel safety and effectiveness. The typical project will be two years or less, although three-year projects will be considered. Contracts awarded as a result of these BAAs historically average around $300K or less cost annually. This information is provided for informational purposes only to provide a sense of scope desired by NAVSEA. This is not an obligatory value and pre-proposals/proposals valued above or below will be considered. However, budgetary constraints are a deciding factor in the selection for award. a. Diving: This interest area is comprised of five task areas focused on items that impose limitations on diver capabilities, specifically: breathing gas supply; human performance; protection from the undersea environment; decompression; and tools, transportation and training. Focus areas for each task are: Breathing Gas Supply (product goal should meet both US Navy General Specification for Diving and Manned Hyperbaric Systems and US Navy Dive Manual requirements): Improve carbon dioxide (CO2) scrubbing materials or systems (i.e. canister systems), used for both free-swimming (i.e. underwater breathing apparatuses (UBAs)) and fixed systems (i.e. recompression chambers), that extend diving duration; Develop portable, minimal power input, ambient oxygen (O2) concentrators capable of working in conjunction with existing diving air compressors; Improve helium reclaim systems to support mixed gas and saturation diving systems and compact, portable mix-making system to reduce large gas storage logistical footprints; Develop CO2 sensor and improve O2 sensors for measuring ppO2 in closed-circuit UBA; Develop innovative diluent gas solutions that combine the advantages of nitrogen’s abundance and availability and helium’s non-narcotic properties; Develop high-pressure air flasks, hoses and regulators, with high pressure defined for this purpose as greater than 5,000 pounds per square inch (psi), for surface-supplied diving (SSD) emergency gas supplies (EGS) and SCUBA/ closed and semi-closed UBAs. Current diver worn EGS is not sufficient to provide organic gas supply for recovery from deepest depths if primary gas source is lost. Human Performance: Improve understanding of oxygen toxicity mechanisms and oxygen toxicity mitigation development; Develop pharmacological or other novel mitigations to prevent or delay pulmonary and CNS oxygen toxicity; Develop and/or refine underwater noise protection strategies, equipment, and diver underwater exposure limits; Improve current comprehension of the environmental and physiological mechanisms via which sound is perceived via wetted auditory interface; Develop permissible exposure limits (PEL) for typical broadband noise sources insonifying the aquatic mission environment; Develop compact, adaptive, wearable acoustic dosimetry technology for use in conjunction with PEL and to inform long-term auditory hazards associated with diving; Develop methods to assess and mitigate diver underwater sound/blast/implosion exposure. Refine the understanding of hypercapnia and its effects on divers and mitigations thereof; Improve understanding of gas (N2, O2, CO2) narcosis to include mitigations and predictions of equivalent narcotic depths; Improve understanding of effects on the human body from immersion, exertion, breathing resistance, and temperature, or a combination thereof, in relation to working underwater; Develop breathing standards for resting and working personnel in dry hyperbaric environments to 6 Atmospheres Absolute (ATA). (3) Protection from the Environment: Improve knowledge of submerged body heat loss/retention to inform development of future heating/cooling systems; Develop analytical tools for exposure planning for deep / long duration diving operations based off know levels of thermal protection and environmental factors (i.e. depth, temperature, etc.); Improve heating/cooling methods/systems for submerged free-swimming divers; Examine novel mechanism for actively cooling a diver underwater. Specifically in helmeted or unhelmeted and tethered and untethered conditions. The system should be capable of functioning in a highly contaminated environment; Improve physical protection for divers in contaminated water (i.e. full encapsulation) to include novel non-permeable membranes; Improve equipment and procedures used to decontaminate divers and diving gear; Improve equipment and/or procedures to detect and quantify biologic and/or chemical contamination on-site within 24 hours of diving; Develop permissible exposure limits for common biological/chemical contaminants for risk mitigation planning. (4) Decompression: Develop/test decompression models valid across the full spectrum of U.S. Navy diving, including diving to depths beyond 300 fsw; Develop pharmacological or other novel mitigations for preventing or treating decompression sickness; Improve decompression sickness diagnosis through, but not limited to, the utilization of algorithms; Improve decompression guidance using alternate gas mixtures. (5) Tools, Transportation and Training: Improve diver communications, both wired and through-water; Improve the ability to track diver location underwater from surface support craft; Improve through-water data communication for divers (text, navigation, biometrics); Improve diver propulsion devices to include diver worn and diver as passenger. b. Submarine Escape and Rescue: This interest area relates to optimizing submariner survival in a disabled submarine event. Focus areas are: Development of rapid, accurate methods to assess a disabled submarine (DISSUB) atmosphere, with focus on Submarine Escape Action Limit (SEAL) gases, to internal pressures up to 6 ATA; Develop novel means to mitigate oxygen toxicity (Pulmonary and CNS) aboard a pressurized disabled submarine; Develop novel means to accelerate or eliminate saturation decompression of a pressurized disabled submarine (DISSUB) survivors, including but not limited to, greater oxygen use; Evaluation of the utility of non-hyperbaric interventions to prolong survival and accelerate decompression from a pressurized DISSUB; Evaluation of the impact of starvation, dehydration, sleep deprivation, and/or gas narcosis at 5 atmospheres absolute (ATA) on decision making in a pressurized DISSUB; Improve understanding and guidance of thermal stress (with focus on hyperthermia) and associated fluid loss in a pressurized DISSUB and rescue vehicles to 5 ATA by: Development and evaluation of physiological heat stress limits based on time and environmental conditions, and Development and evaluation of heat mitigation measures (body cooling) under conditions of increased temperature, humidity, and elevated CO2 (2.5 - 3%); Improve understanding and guidance for mitigation of surface interval decompression sickness (DCS) risk associated with rescue using either the Pressurized Rescue Module (PRM) or the Submarine Rescue Chamber (SRC) after saturation dropout or aborted decompression, including, but not limited to, mitigation with various periods of oxygen pre-breathing and/or other non-hyperbaric interventions e.g. pharmacological; Develop procedures to fully decompress pressurized rescuees within the PRM if needed; Improve guidance for hypothermia prevention in submarine escape scenarios using existing Submarine Escape and Surface Survival Personnel Equipment (SESSPE); Improve Guard Book guidance, procedures, and related senior survivor decision tools, to include reducing the risk of pulmonary oxygen toxicity for rescuees; Improve care of escape and rescue casualties within the U.S. Navy Submarine Rescue Diving and Recompression System (SRDRS), to include critical care and casualty assessment; Improvement of current concepts of rescuee triage, holding, and movement, including assessment of the adequacy of established procedures and available equipment, for rescues involving the PRM and the SRC; Improvement of current tracking of rescuee triage, holding, and movement. c. Additional interest items include any equipment, procedure, or medical treatment protocol, not specifically listed above, that could be used to improve the safety or effectiveness of Navy divers or submarine rescue operations. 2. Instructions for Preparation of Pre-proposal and Proposals a. Proposals to this BAA are reviewed using a two-step process. To be considered for an award, respondents are first required to submit a pre-proposal. Multiple submissions are allowed and encouraged if a respondent wishes to be considered for award under more than one of the task areas identified above. Separate submissions would be required for each area of interest. (1) For FY26, the pre-proposal submission deadline is no later than 3:00 PM EST, 30 November 2024. If the pre-proposal submission is selected, the second step will be a request for full-proposals. The deadline for full-proposal submission is no later than 3:00 PM EST, 28 February 2025. Proposals received after the due date will be considered only if funding remains available. These dates are applicable to work beginning in the funding cycle starting 1 October 2026. (2) For FY27, the pre-proposal submission deadline is no later than 3:00 PM EST, 30 November 2025. If the pre-proposal submission is selected, the second step will be a request for full-proposals. The deadline for full-proposal submission is no later than 3:00 PM EST, 28 February 2026. Proposals received after the due date will be considered only if funding remains available. These dates are applicable to work beginning in the funding cycle starting 1 October 2027. b. This synopsis constitutes a Broad Agency Announcement (BAA) per FAR 6.102(d)(2)(i). The Step One pre-proposal shall be three to five pages of text using the format provided with this BAA, and should include an estimate of overall costs (including indirect costs) for each year of the proposed effort. Pre-proposals will be evaluated based on the criteria specified below using a scale of 1 (lowest) to 10 (highest). c. The highest rated pre-proposal responses will be invited to submit a Step Two full technical and cost proposal on all or part of their pre-proposal submission. The technical proposal will be submitted using the format provided with this BAA and not be more than 20 pages excluding curriculum vitae and supporting documentation that would be included in the Appendix. Any such invitation does not obligate the U.S. Government to make an award. Offerors are also advised all awards are subject to the Defense Contract Audit Agency (DCAA) contract audit process. Any proposal that involves animal research must comply with the following requirements before a contract can be awarded: 7 U.S.C. 2131-2159 and 9 CFR parts 1 thru 4, SECNAVINST 3900.38C, DoDINST 3216.01 and Defense Federal Acquisition Regulation Supplement (DFARS) 252.235-7002 Animal Welfare, as applicable. Additionally, any proposal that involves human subject research must comply with the following requirements before a contract can be awarded: 32 CFR 219, DoDINST 3216.02, the SECNAVINST 3900.39 series, and all applicable sections of the 21 CFR as outlined in DFARS 252.235-7004 Protection of Human Subjects. Each pre-proposal and full proposal must state that it is submitted in response to this BAA. This BAA provides no funding for pre-proposal or subsequent proposal development purposes. Proposals will be evaluated based on the criteria specified below. 3. Criteria for Scoring and Ranking Pre-proposals and Proposals, their Relative Importance, and the Method of Evaluation. a. Pre-proposal and full technical proposal submissions will be evaluated on: (1) the basis of innovation and scientific merit; (2) the relevance to diving and submarine escape and rescue; (3) the overall value to the U.S. Government and affordability of the proposal; (4) the likelihood of achieving success, based on the Offeror’s abilities, capabilities, strengths, and weaknesses, all of which impact the ability to achieve the proposal objectives; (5) the potential benefits of any proposed data rights (if applicable); (6) the ability of the offeror to efficiently managing their project, funds and timely completion of work products; and (7) The overall impression of the project by the expert reviewer(s). These criteria are all of equal importance. b. Selection of proposals for award will be based on the total evaluated score of the items above. c. This is to notify potential Offerors that each contract that may be placed under this announcement to an institution of higher education must include the following clause: "As a condition for receipt of funds available to the Department of Defense (DoD) under this award, the recipient agrees that it is not an institution that has a policy of denying, and that it is not an institution that effectively prevents the Secretary of Defense from obtaining for military recruiting purposes: (A) an entry to campuses or access to students on campuses; or (B) access to directory information pertaining to students. If the recipient is determined, using procedures established by the Secretary of Defense to implement Section 558 of Public Law 103-337 (1994), to be such an institution during the period of performance of this agreement, and therefore to be in breach of this clause, the Government will cease all payments of DoD funds under this agreement and all other DoD grants and cooperative payments unilaterally for material failure to comply with the terms and conditions of award. If your institution has been identified under the procedures established by the Secretary of Defense to implement Section 558, then: (1) no funds available to DoD may be provided to your institution through any contract, including any existing contract, (2) as a matter of policy, this restriction also applies to any cooperative agreement, and (3) your institution is not eligible to receive a contract or cooperative agreement in response to this solicitation." d. Historically Black Colleges and Universities (HBCU) and Minority Institutions (MI) are encouraged to submit pre-proposals or join others in submitting pre-proposals; however, no portion of this BAA will be set aside for HBCU and MI participation due to the impracticality of reserving discrete and severable areas of submarine escape and rescue, and diving for exclusive competition among these entities. This announcement constitutes a Broad Agency Announcement (BAA) as contemplated in FAR 6.102(d)(2)(i). The Government reserves the right to select for award all, some, or none of the proposals received in response to this announcement. 4. Pre-proposals and subsequent full proposals shall be submitted to: Dr. David Southerland, david.g.southerland.civ@us.navy.mil; usn.washington.sea-00.mbx.sea-00c-dsbd@us.navy.mil, lisa.m.grayum.civ@us.navy.mil, and daniel.w.kough2.civ@us.navy.mil. Attn: BAA-25-G-01. Offerors are to follow the sample format for submission of pre-proposals and proposals as found in enclosures (1) and (2) of this BAA. a. All pre-proposals and full-proposals will be acknowledged within 7 working days after the published due date. If no acknowledgement is received after 7 working days it is the responsibility of the submitter to contact the Naval Sea Systems Command office at 202-781-3854 to verify that their submission has been received. Pre-proposals and full-proposals will not be returned after evaluation. General and technical questions regarding this announcement should be sent to: usn.washington.sea-00.mbx.sea-00c-dsbd@us.navy.mil b. The point of contact for information regarding contractual issues is Ms. Lisa Grayum, Contracting Officer, at email: lisa.m.grayum.civ@us.navy.mil with copy to daniel.w.kough2.civ@us.navy.mil. The following additional information is provided: (1) Proposals may be submitted by any governmental agency, commercial firm, individual, non-profit, or institution of higher education. (2) Offerors must be current in System for Award Management (SAM). c. Phase II of the proposal selection process for non-government institutions (contractors) will consist of a request from the U.S. Government to the Offeror(s) for full technical and cost proposals to support the Navy in one or more of the primary areas of interest listed in paragraph 1 above. An Offeror can be considered for contract award only upon preparation and submittal of a fully compliant Phase II Proposal. In the event that a Phase II technical and cost proposal is requested, the applicable Request for Proposal will contain the terms and conditions and clauses to be incorporated in the potential contract. 5. Any contract(s) awarded based on responses to this BAA are considered to be the result of full and open competition (see FAR 6.102(d)(2)(i)) and in full compliance with the provisions of Public Law (PL) 98-369, “The Competition in Contracting Act of 1984.”
69%
Market Research02/28/2026
INTRODUCTION: The National Institute of Allergy and Infectious Diseases (NIAID), one of 27 institutes of the NIH, an agency within the Department of Health and Human Services (DHHS); conducts and supports research to understand, treat, and ultimately prevent the myriad infectious, immunologic, and allergic diseases that threaten the health and longevity of human lives.Through a variety of research grants and contracts, NIAID’s Division of Microbiology and Infectious Diseases (DMID) specifically supports extramural research to develop new medical interventions against infectious disease threats to include drug-resistant pathogens. NIAID/DMID intends to use this BAA to help address goals articulated in a number of strategic plans, such as in the Public Health Emergency Medical Countermeasures Enterprise Strategy and Implementation Plan (https://aspr.hhs.gov/PHEMCE/2024-PHEMCE-SIP/Pages/default.aspx), as well as current prioritized antimicrobial resistant threats identified by national death and infection estimates as determined by the Centers for Disease Control and Prevention’s (CDC) to prevent and control antimicrobial resistance (https://www.cdc.gov/antimicrobial-resistance/data-research/threats/index.html). In addition, NIAID/DMID intends to use this BAA to encourage projects that align with the NIH priorities of enhancing rigor & reproducibility, improving biosafety and biosecurity, and the use of complementary non-animal testing methods where appropriate. This Broad Agency Announcement (BAA) is soliciting proposals to advance the research and development of promising candidate therapeutics, vaccines, and diagnostics for infectious diseases in each of three (3) Research Areas described below and more thoroughly discussed in the attached BAA Solicitation. An offeror should carefully review the content of the BAA Solicitation No. HHS-NIH-NIAID-BAA2026-1 for the comprehensive information regarding all requirements, the technical objective of each Research Area of this BAA Solicitation, instructions regarding the proposal submission, and a description of the evaluation and award process. Please note, due to the competitive nature of the BAA Solicitation, the NIAID is unable to offer advice or feedback regarding an offeror’s specific technical approach. Offerors should exercise their professional judgment when compiling their proposals in line with the requirements and specifications of the BAA Solicitation. Research Area 001 - Vaccine Candidates: The objective is to develop vaccine candidates through an early phase clinical trial that use a needle free (i.e., alternative to classical needle and syringe, see below for description) route of delivery to protect against infections caused by viral pathogens that include but are not limited to respiratory and vector borne viruses. The scope of this vaccine research area includes the preclinical development of a needle free vaccine candidate, IND enabling studies, limited process development, Good Manufacturing Practice (GMP) compliant manufacturing, regulatory submissions to the U.S. Food and Drug Administration (FDA) and conduct of a Phase 1 or early Phase 2 clinical trial. The scope of work must include a clinical trial. Offerors must propose a single vaccine candidate for protection against a specific viral pathogen. The vaccine candidate may provide a breadth of protection against other viral strains or viruses. A strong justification is required to support (1) the proposed vaccine antigen and platform for the disease indication, (2) the use of a clinically relevant adjuvant (if needed), and (3) a clinically relevant needle free route of delivery. Research Area 002 - Therapeutic Candidates: The objective is to develop safe, effective, new therapeutic products that will improve patient outcomes against serious infectious diseases for which there are no approved therapeutics, or for those that are refractory to treatment despite appropriate antimicrobial therapy or due to pathogen resistance. Infectious diseases caused by the following viruses, bacteria and fungi pathogens are targeted: Viral hemorrhagic fever viruses (e.g., EBOV, SUDV, MARV, LASV, hantavirus) https://www.cdc.gov/viral-hemorrhagic-fevers/about/index.html Encephalitic paramyxoviruses (e.g. hendra virus, nipah virus) Picornaviruses (broad spectrum approaches that include EV68, EV70 and coxsackie virus) At least two of the following (i.e., addressed with a broad spectrum antimicrobial): susceptible and carbapenem-resistant Enterobacteriaceae (CRE), susceptible and multidrug resistant (MDR) Pseudomonas aeruginosa, and susceptible and Carbapenem-resistant Acinetobacter (CRAB), with potential to improve patient outcomes in the clinic; Candida auris, Cryptococcus spp., Aspergillus fumigatus, and/or Mucorales Adjunct medical interventions to support or enhance effectiveness of antimicrobial agents to address underlying pathology that is not resolved after clearance of pathogens, may be considered. Important notice to Offerors: For this Research Area, “therapeutic” activity means curing disease by eliminating or substantially reducing infective pathogens by administering antimicrobial pharmaceutical agents, with or without a host-directed therapy. Additionally, proposed therapeutic products should consider the impact on a healthy microbiome. Preventative treatments are not included in the scope of this Research Area. A therapeutic candidate refers to an advanced lead series, preclinical candidates, or a clinical candidate, that is a new chemical entity. This includes small molecules, natural products, nucleosides, or peptides of </= 40 amino acids, monoclonal antibodies, nanobodies, nanobody conjugate/fusion products, microbiome-based therapeutics or bacteriophages. Research Area 002 will support lead optimization, pre-clinical Investigational New Drug (IND) enabling studies, and Phase 1 clinical trials (or proof of concept Phase 2 clinical trials) of lead candidates with demonstrated therapeutic activities. This includes support for traditional, novel (e.g., small molecules) and non-traditional (e.g., including but not limited to phage, and host-directed) therapeutics for infectious diseases where patients lack effective interventions, as well as therapeutics that promote host-mediated resolution of disease. The scope of support differs depending on the developmental stage of the project being proposed, which is further discussed in the BAA Solicitation. Research Area 003 - In Vitro Diagnostics The objective of Research Area 003 is to develop innovative, technology platforms that will speed detection and identification of infectious viruses covering a broad panel of virus families, including viruses causing acute infections as well as those causing chronic infections. Technology platform innovation to achieve faster actionable sequencing results (approaching 2 hr) direct from primary clinical specimens, as well as more accessible workflow and configuration (i.e., point-of-care) are preferred. Furthermore, full sample-to-answer platform solutions are preferred. The system should accept specimen volumes from 0.5 to 5 milliliters (mL). The system should include nearly full automation (little or no hands-on activity after specimen has been loaded into system). Sample preparation components of the system should yield sufficient analyte recovery from a starting titer of 10-100 genomic copies per mL of biofluid for downstream analysis, including detection, identification, and characterization of the nucleic acid material. Innovations during platform development might include, for example: Automated sample prep for high recovery from low pathogen load. Faster specimen-to-answer for total test time <2 hours. Broad viral pathogen detection capability, covering one or more members of the priority pathogen families (see below). Targeted, or even untargeted pathogen detection and identification via long-read sequencing or other detection methods. Multiple specimen throughput per run for reduced cost. Analytical sensitivity approaching 5-50 genome copies per mL of starting biofluid. Assay reconfigurability to respond rapidly to a novel pathogen in days or weeks rather than months (i.e., agnostic diagnostic solution). Priority Pathogens The diagnostic test system must detect analytes from at least one, and preferably several, of the following agents and markers: Arenaviridae (e.g., Lassa virus) Phenuviridae (e.g., Rift Valley fever virus) Peribunyayviridae (e.g., Oropouche virus) Hantaviridae (e.g., Hantavirus) Nairoviridae (e.g., Crimean Congo Hemorrhagic fever virus) Filoviridae (e.g., Sudan virus, Ebola virus, Marburg virus) Flaviviridae (e.g., Hepatitis C virus, West Nile Virus) Paramyxoviridae (e.g., Nipah virus) Togaviridae (e.g., Chikungunya virus) Picornaviridae (e.g., Enterovirus) PROPOSAL SUBMISSION: Proposals Due Date and Time – December 8, 2026, 3:00 PM Eastern Time For this solicitation, the NIAID requires proposals to be submitted online via the NIAID electronic Contract Proposal Submission (eCPS) website. Submission of proposals by any other method is not permitted. For directions on using eCPS, go to the website: https://ecps.nih.gov and thenclick on "How to Submit."
68%
Solicitation12/08/2026

Additional Details

Solicitation Number

N0002427S0001

Archive Date

Nov 30, 2028

Office Address

WASHINGTON NAVY YARD, DC, 20376-5000